David Kirske

Insider Reports History

Entity
Individual
Location
C/O Cti Biopharma Corp., 3101 Western Ave., Suite 600, Seattle, WA
Signature
/s/ Adam R. Craig, attorney-in-fact for David Kirske
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Kirske:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CTI BIOPHARMA CORP EVP, Chief Financial Officer Common Stock 0 $9.10 Jun 26, 2023 Direct
CTI BIOPHARMA CORP EVP, Chief Financial Officer Stock Option (Right to Buy) 0 Jun 26, 2023 Direct

Insider Reports Filed by David Kirske

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTIC CTI BIOPHARMA CORP Jun 26, 2023 9 -$160K 4 Jun 26, 2023 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Mar 14, 2023 1 $0 4 Mar 16, 2023 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Dec 29, 2022 16 -$272K 4 Jan 3, 2023 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Oct 4, 2022 9 -$11.2K 4 Oct 6, 2022 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Sep 29, 2022 12 -$719K 4 Oct 3, 2022 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Jun 30, 2022 4 -$94.4K 4 Sep 20, 2022 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Jun 17, 2022 6 -$198K 4 Jun 17, 2022 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Jun 14, 2022 3 -$45.5K 4 Jun 16, 2022 EVP, Chief Financial Officer
CTIC CTI BIOPHARMA CORP Jun 30, 2021 3 $7.62K 4 Mar 11, 2022 EVP, Chief Financial Officer